Literature DB >> 521829

Multiple system atrophy with autonomic failure: clinical, histological and neurochemical observations on four cases.

E G Spokes, R Bannister, D R Oppenheimer.   

Abstract

Four cases of progressive autonomic failure are described, in all of which there were additional non-autonomic neurological abnormalities, including pyramidal, extra-pyramidal and cerebellar features. Histological examination revealed cell degeneration in the substantia nigra, putamen and intermediolateral columns of the spinal cord as a common pathological finding. In addition, 3 cases showed loss of Purkinje cells in the cerebellum and degeneration of pontine nuclei and inferior olivary nuclei. In one case there was cell loss from the locus coeruleus, caudate nucleus, vestibular nuclei and dorsal vagal nuclei. These were, therefore, cases of multiple system atrophy. Neurochemically, a common feature was a profound depletion in dopamine and noradrenaline from brain regions which are normally rich in these catecholamines. Central cholinergic systems appeared to be involved also, but to a variable degree.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 521829     DOI: 10.1016/0022-510x(79)90073-x

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  33 in total

Review 1.  Growth hormone stimulation tests in the differential diagnosis of Parkinson's disease.

Authors:  Maria Teresa Pellecchia; Rosario Pivonello; Annamaria Colao; Paolo Barone
Journal:  Clin Med Res       Date:  2006-12

2.  Multimodal MRI evaluation of parkinsonian limbic pathologies.

Authors:  Ernest W Wang; Guangwei Du; Mechelle M Lewis; Eun-Young Lee; Sol De Jesus; Sangam Kanekar; Lan Kong; Xuemei Huang
Journal:  Neurobiol Aging       Date:  2019-01-16       Impact factor: 4.673

3.  Does signal-attenuation on high-field T2-weighted MRI of the brain reflect regional cerebral iron deposition? Observations on the relationship between regional cerebral water proton T2 values and iron levels.

Authors:  D J Brooks; P Luthert; D Gadian; C D Marsden
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-01       Impact factor: 10.154

4.  Different iron-deposition patterns of multiple system atrophy with predominant parkinsonism and idiopathetic Parkinson diseases demonstrated by phase-corrected susceptibility-weighted imaging.

Authors:  Y Wang; S R Butros; X Shuai; Y Dai; C Chen; M Liu; E M Haacke; J Hu; H Xu
Journal:  AJNR Am J Neuroradiol       Date:  2011-11-03       Impact factor: 3.825

5.  Neuropsychological pattern of striatonigral degeneration: comparison with Parkinson's disease and progressive supranuclear palsy.

Authors:  B Pillon; N Gouider-Khouja; B Deweer; M Vidailhet; C Malapani; B Dubois; Y Agid
Journal:  J Neurol Neurosurg Psychiatry       Date:  1995-02       Impact factor: 10.154

6.  Airway dysfunction in patients with Parkinson's disease.

Authors:  J L Izquierdo-Alonso; F J Jiménez-Jiménez; F Cabrera-Valdivia; M Mansilla-Lesmes
Journal:  Lung       Date:  1994       Impact factor: 2.584

7.  MRI in autonomic failure.

Authors:  R T Brown; R J Polinsky; G Di Chiro; B Pastakia; L Wener; J T Simmons
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

8.  The use of lisuride in the treatment of multiple system atrophy with autonomic failure (Shy-Drager syndrome).

Authors:  A J Lees; R Bannister
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-04       Impact factor: 10.154

9.  Clinical Implications of Cardiac-MIBG SPECT in the Differentiation of Parkinsonian Syndromes.

Authors:  Dong Hoon Shin; Phil Hyu Lee; Oh Young Bang; In Soo Joo; Kyoon Huh
Journal:  J Clin Neurol       Date:  2006-03-20       Impact factor: 3.077

10.  Multiple system atrophy: natural history, MRI morphology, and dopamine receptor imaging with 123IBZM-SPECT.

Authors:  J B Schulz; T Klockgether; D Petersen; M Jauch; W Müller-Schauenburg; S Spieker; K Voigt; J Dichgans
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-09       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.